Intuit Earnings Report Challenges Morgan Stanleys Analyst Outlook Shah Metacorp Surges 6 on 498 Crore Rights Issue for Expansion and Renewable Energy Entry Inflation Expected to Reach 6 in Q2 According to Top Economic Forecasters XFAB Shares Surge Following Social Media Post Retail Activity Drives Trading on Tradegate Analysts Eye April Jobs Report as Labor Market Shows Signs of Slowing Seaport Research Highlights Data Center Power Demand as Growth Catalyst for Texas Instruments TXN DAKT Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Disappointing Start Eagle Point Credit Company Inc ECC Q4 2025 Earnings EPS Surpasses Estimates Stock Gains 21 CleanSpark Q1 2026 Earnings Significant EPS Miss Amid Bitcoin Mining Volatility NTRS Q1 2026 Earnings EPS Surges Past Estimates Shares Edge Higher Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues Workiva WK Q1 2026 Earnings EPS Surprises to the Upside Amid Slight Stock Decline Satellogic Warrants SATLW Surge 45 as Momentum Builds Quince Therapeutics QNCX Edges Higher Navigating Key Levels Near Resistance Teladoc Health TDOC Holds Steady at 657 Consolidation Near Key Support James Hardie Industries JHX Rises 267 Testing Key Resistance as Volume Picks Up Callaway Golf Company CALY Holds Ground With Modest Gains Key Levels in Focus Ral Castro Indictment Sparks Mixed Reactions Among CubanAmerican Community Geopolitical Tensions Could Affect CubaRelated Investments Acadian Asset Management Inc AAMI Q1 2026 Earnings Strong EPS Beat Signals Resilience in Volatile Markets CNX Resources CNX Slips 164 as Stock Holds Above Key Support Level Vera Therapeutics VERA Edges Lower as Stock Consolidates Near Key Resistance Level Consensus Cloud Solutions CCSI Rallies 256 as Bulls Challenge Resistance Zone ChoiceOne Financial Services COFS Holds Steady Near Support After Minor Decline SkyWest Inc SKYW Climbs 185 as Regional Aviation Demand Remains Robust Passage Bio Inc PASG Edges Higher Testing Key Resistance Levels Teck Resources Shares Dip Slightly as Key Support Levels Remain in Focus PRAX Shows Strength Praxis Precision Medicines Gains 245 as Biotech Momentum Builds